E-LIB Suche - Ergebnisse für: Wagner, Anita K

1

Regulatory histories of recently withdrawn ovarian cancer t..:

Shahzad, Mahnum ; Naci, Huseyin ; Esselen, Katharine M...
Journal of Pharmaceutical Policy and Practice. 17 (2024) 1 - p. , 2024

Link: https://doi.org/10.1080/..

2

Overall survival benefits of cancer drugs initially approve..:

Naci, Huseyin ; Zhang, Yichen ; Woloshin, Steven...
The Lancet Oncology. 25 (2024) 6 - p. 760-769 , 2024

Link: https://doi.org/10.1016/..

3

Cancer drug indication approvals in China and the United St..:

Wei, Yuxuan ; Zhang, Yichen ; Xu, Ziyue...
The Lancet Regional Health - Western Pacific. 45 (2024) - p. 101055 , 2024

Link: https://doi.org/10.1016/..

4

Effect of a national antibiotic stewardship intervention in..:

Xu, Sen ; Kitchen, Chenai ; Liu, Yang...
International Journal of Antimicrobial Agents. 62 (2023) 4 - p. 106936 , 2023

Link: https://doi.org/10.1016/..

5

Communication of anticancer drug benefits and related uncer..:

Davis, Courtney ; Wagner, Anita K ; Salcher-Konrad, Maximilian...
BMJ. , 2023

Link: https://doi.org/10.1136/..

6

Marketing authorisation and pricing of FDA-approved cancer ..:

Ivama-Brummell, Adriana M. ; Marciniuk, Fernanda L. ; Wagner, Anita K....
The Lancet Regional Health - Americas. 22 (2023) - p. 100506 , 2023

Link: https://doi.org/10.1016/..

7

Newly approved cancer drugs in China — innovation and clini..:

Zhang, Yichen ; Wagner, Anita K. ; Guan, Xiaodong
Nature Reviews Clinical Oncology. 20 (2023) 3 - p. 135-136 , 2023

Link: https://doi.org/10.1038/..

8

The impact of government reimbursement negotiation on targe..:

Yang, Yu ; Zhang, Yichen ; Wagner, Anita K...
Journal of Global Health. 13 (2023) - p. , 2023

Link: https://doi.org/10.7189/..

9

Ultraexpensive gene therapies, industry interests and the r..:

Ivama-Brummell, Adriana Mitsue ; Wagner, Anita K ; Pepe, Vera Lúcia Edais.
BMJ Global Health. 7 (2022) 3 - p. e008637 , 2022

Link: https://doi.org/10.1136/..

10

Forecasting essential childhood cancer drug need: An innova..:

Hughes, Terence M. ; Empringham, Brianna ; Wagner, Anita K....
Cancer. 127 (2021) 16 - p. 2990-3001 , 2021

Link: https://doi.org/10.1002/..

11

Integrating public preferences into national reimbursement ..:

Leopold, Christine ; Lu, Christine Y. ; Wagner, Anita K.
BMC Health Services Research. 20 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

12

1-year impact of supervision, performance assessment, and r..:

Trap, Birna ; Sembatya, Moses N. ; Imi, Monica...
Journal of Pharmaceutical Policy and Practice. 13 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

13

The Complex Cancer Care Coverage Environment — What is the ..:

Leopold, Christine ; Haffajee, Rebecca L. ; Lu, Christine Y..
Journal of Law, Medicine & Ethics. 48 (2020) 3 - p. 538-551 , 2020

Link: https://doi.org/10.1177/..

14

Essential medicines for universal health coverage:

Wirtz, Veronika J ; Hogerzeil, Hans V ; Gray, Andrew L...
Kazan medical journal. 100 (2019) 1 - p. 4-111 , 2019

Link: https://doi.org/10.17816..

15

Out-of-Pocket Cancer Care Costs and Value Frameworks: A Cas..:

Leopold, Christine ; Araujo-Lane, Carina ; Rosenberg, Carol..
PharmacoEconomics - Open. 4 (2019) 2 - p. 389-392 , 2019

Link: https://doi.org/10.1007/..